Mr. Beat Up

speaker

680 appearances 3 recordings 1 series first heard Jun 2026 last heard 8 Jul

Mr. Beat Up’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 3 in all, peaking in Jun 2026 with 2.

Appearances

newest first · ▶ plays the moment

Equity Mates Investing Podcast · Longevity: Can We Add Another 30 Years? | The Decade Ahead · 8 Jul 2026 podcast

What if I've missed something?

What if I'm not ready?

And when you've taken the time to set yourself up right, you start to wonder what's the best that could happen.

To learn more, search ANZ Business Start Right.

Thanks to ANZ for sponsoring this series and helping us keep all of our content free.

Don't clip that.

All right.

Well, that has got me excited.

I mean, this whole episode has got me excited.

We're lucky to have been born when we were born and where we were born.

I think we can't lose sight of that.

So the question then becomes like, who are the big players?

Where are the investment opportunities and sort of who's on the forefront of different technologies?

And for me, biotech is a...

It's a fragmented field with notable choke points.

And so there's huge amounts of research being done in university labs, in small, pure play biotechs.

And then the big players do have some meaningful R&D programs as well.

The choke point comes in the clinical trials process.

And particularly, I remember...

A conversation that I listened to with David Ricks, the CEO of Eli Lilly, and he was talking about like one of Eli Lilly's long-term competitive advantages is that they can do a stage three clinical trial cheaper and faster than anyone else.

Showing 141–160 of 680 · page 8 of 34